COVID-19 Providing "Nexstetho" to Yusho-kai, which is in charge of visiting home care patients

Supporting the creation of indicators to clarify the indications for hospitalization and the prediction of deterioration in the limited information available in home care.


ShareMedical, Inc. announced that it has provided the digital stethoscope device "Nexstetho" to Yusho-kai Medical Corporation (President and Medical Director, Dr. Jun Sasaki), which provides medical care for patients receiving home treatment for the new coronavirus. At the request of the Tokyo Metropolitan Medical Association, Yusho-kai is now actively engaged in providing home medical care as a last safety net for patients receiving home treatment for the new coronavirus.

株式会社シェアメディカル × 医療法人社団悠翔会

医療法人社団悠翔会 理事長・診療部長 佐々木 淳 医師

At the request of the Tokyo Metropolitan Medical Association, Yusho-kai is now actively involved in providing home medical care to patients with corona at home. At the same time, however, they are keenly aware of the difficulty in determining the indications for hospitalization of the rapidly increasing number of isolated patients at home. Dr. Sasaki focused on the stethoscope, which is a simple examination device. Dr. Sasaki focused on the stethoscope, which is a simple testing device, and asked for cooperation from ShareMedical, Inc. to see if he could publish a paper on the new coronavirus and "Nexstetho". In the future, Dr. Sasaki plans to use the stethoscope in home visits to patients undergoing treatment at home for diagnosis.


ShareMedical, Inc. is conducting clinical research on AI-based digital auscultation devices with St. Marianna University School of Medicine, and also offers a multifunctional online medical service called "Nexstetho Synapse" that combines real-time remote audiology and online medical care, for which it holds the basic patent. The company is also promoting joint research on bio-sound using audiometric data with universities, hospitals, and companies in Japan and abroad, and has many case studies.


Endorsement from Dr. Jun Sasaki.

What to Expect from Nexstetho in the Care of COVID-19 Patients COVID-19 is a designated infectious disease, which means that people cannot freely visit hospitals of their own choice. The number of areas where patients cannot be transported even if they call for an emergency, or cannot be hospitalized immediately even if they become seriously ill, is increasing. Under these circumstances, the role of home medical care is naturally becoming larger. However, even if a doctor visits a patient at home, there are limits to the tests and treatments that can be performed there. Under such severe circumstances, it is necessary to accurately diagnose the severity of the patient's illness and provide appropriate treatment. As CT and other modalities are not available as in hospitals, we need to reevaluate the value of stethoscopy. However, the stethoscope is an instrument that connects the doctor's body to the patient's body. From the viewpoint of infection control, its use is not recommended. Therefore, stethoscopy has been omitted in coronary care. Nexstetho, however, can wirelessly transmit audio information from auscultation, so the physician is not exposed to the risk of infection. In addition, by digitally recording the audio information, it is possible to understand how new coronary pneumonia and its associated interstitial changes are reflected in the auscultatory findings. Also, what kind of auscultatory findings are important for prognostic factors and treatment selection? It should be possible to evaluate them. In a prolonged pandemic, I expect that we doctors will have one more weapon in our arsenal.




36 views0 comments